Osaic Holdings’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-295
| Closed | -$304 | – | 7465 |
|
2024
Q4 | $304 | Hold |
295
| – | – | ﹤0.01% | 6947 |
|
2024
Q3 | $395 | Hold |
295
| – | – | ﹤0.01% | 6835 |
|
2024
Q2 | $384 | Buy |
295
+248
| +528% | +$323 | ﹤0.01% | 6842 |
|
2024
Q1 | $81 | Sell |
47
-50
| -52% | -$86 | ﹤0.01% | 6856 |
|
2023
Q4 | $143 | Hold |
97
| – | – | ﹤0.01% | 6921 |
|
2023
Q3 | $117 | Sell |
97
-2,092
| -96% | -$2.52K | ﹤0.01% | 7036 |
|
2023
Q2 | $3.26K | Sell |
2,189
-935
| -30% | -$1.39K | ﹤0.01% | 6396 |
|
2023
Q1 | $4.86K | Buy |
3,124
+47
| +2% | +$73 | ﹤0.01% | 6265 |
|
2022
Q4 | $5K | Sell |
3,077
-21,740
| -88% | -$35.3K | ﹤0.01% | 6270 |
|
2022
Q3 | $50K | Buy |
24,817
+22,022
| +788% | +$44.4K | ﹤0.01% | 4894 |
|
2022
Q2 | $2K | Buy |
2,795
+1,700
| +155% | +$1.22K | ﹤0.01% | 6852 |
|
2022
Q1 | $3.47M | Sell |
1,095
-30
| -3% | -$95.1K | 0.01% | 1473 |
|
2021
Q4 | $17K | Sell |
1,125
-1,423
| -56% | -$21.5K | ﹤0.01% | 5877 |
|
2021
Q3 | $46K | Sell |
2,548
-7,515
| -75% | -$136K | ﹤0.01% | 5176 |
|
2021
Q2 | $143K | Sell |
10,063
-32,150
| -76% | -$457K | ﹤0.01% | 4175 |
|
2021
Q1 | $621K | Buy |
42,213
+29,442
| +231% | +$433K | ﹤0.01% | 2651 |
|
2020
Q4 | $248K | Buy |
+12,771
| New | +$248K | ﹤0.01% | 3279 |
|